Clover Health Files 8-K for Routine Disclosures

TL;DR

CLOV filed an 8-K, mostly routine stuff, no major news.

AI Summary

Clover Health Investments Corp. filed an 8-K on June 14, 2024, to report information under Regulation FD and to file financial statements and exhibits. The filing does not contain specific financial figures or new material events but serves as a routine disclosure.

Why It Matters

This filing indicates Clover Health is adhering to its reporting obligations with the SEC, providing transparency to investors regarding its corporate actions and financial disclosures.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for disclosures and exhibits, not indicating any new risks or material adverse events.

Key Players & Entities

• CLOVER HEALTH INVESTMENTS, CORP. (company) — Registrant
• June 14, 2024 (date) — Date of earliest event reported
• Delaware (jurisdiction) — State of Incorporation
• 3401 Mallory Lane, Suite 210 Franklin, Tennessee 37067 (address) — Principal Executive Offices
• ( 201 ) 432-2133 (phone_number) — Registrant's Telephone Number

FAQ

Key Financial Figures

• $0.0001 — stered Class A Common Stock, par value $0.0001 per share CLOV The NASDAQ Stock Market

Filing Documents

• clov-20240614.htm (8-K) — 30KB
• exhibit991-starratingsincr.htm (EX-99.1) — 10KB
• 0001801170-24-000124.txt ( ) — 169KB
• clov-20240614.xsd (EX-101.SCH) — 2KB
• clov-20240614_lab.xml (EX-101.LAB) — 22KB
• clov-20240614_pre.xml (EX-101.PRE) — 13KB
• clov-20240614_htm.xml (XML) — 3KB

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. On June 14, 2024, Clover Health Investments, Corp. (the "Company") issued a press release that the Centers for Medicare and Medicaid Services ("CMS") has recalculated the Star ratings of the Company's PPO Medicare Advantage plans for the 2025 payment year, and has increased such plans' rating by 0.5 Stars, to a revised rating of 3.5 Stars, from the original rating of 3.0 Stars. The information set forth in this Item 7.01 (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) List of Exhibits Exhibit No. Description 99.1 Press release dated June 14, 2024

Forward-Looking Statements

Forward-Looking Statements Please note that this report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include statements regarding future events and the Company's future results of operations, financial position, business strategy and future plans. Forward-looking statements are not guarantees of future performance, and you are cautioned not to place undue reliance on such statements. In some cases, you can identify forward looking statements because they contain words such as "may," "will," "should," "expects," "plans," "anticipates," "going to," "can," "could," "should," "would," "intends," "target," "projects," "contemplates," "believes," "estimates," "predicts," "potential," "outlook," "forecast," "guidance," "objective," "plan," "seek," "grow," "target," "if," "continue," or the negative of these words or other similar terms or expressions that concern the Company's expectations, strategy, priorities, plans or intentions. Forward-looking statements in this report include, but are not limited to, statements regarding the anticipated benefits associated with CMS's recalculation of the 2025 payment year Star ratings of the Company's PPO Medicare Advantage plans from 3 Stars to 3.5 Stars, as well as our expectations related to the Company's profitability, liquidity, future performance, future operations and future results. These statements are subject to known and unknown risks, uncertainties and other factors that may cause the Company's actual results, levels of activity, performance or achievements to differ materially from results expressed or implied in this report. Additional information concerning these and other risk factors is contained in the Company's latest Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on March 14, 2024, and in our subsequent report

View Full Filing

View this 8-K filing on SEC EDGAR